J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 586, Number 18, 4401-4408, September 15, 2008 DOI: 10.1113/jphysiol.2008.156695
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
586/18/4401    most recent
jphysiol.2008.156695v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Kern, T. S.
Right arrow Articles by Barber, A. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kern, T. S.
Right arrow Articles by Barber, A. J.
Related Collections
Right arrow Review articles
Right arrow Neuroscience

SYMPOSIUM REPORT

Retinal ganglion cells in diabetes

Timothy S. Kern1 and Alistair J. Barber2

1 Departments of Medicine and Ophthalmology, Case Western Reserve University, Cleveland, OH, USA and Cleveland VAMC Research Service 151, Cleveland, OH, USA
2 The Penn State Retina Research Group, The Ulerich Ophthalmology Research Laboratory, and the Juvenile Diabetes Research Foundation Diabetic Retinopathy Center and Department of Ophthalmology, Penn State College of Medicine, Hershey, PA 17033, USA

Diabetic retinopathy has long been recognized as a vascular disease that develops in most patients, and it was believed that the visual dysfunction that develops in some diabetics was due to the vascular lesions used to characterize the disease. It is becoming increasingly clear that neuronal cells of the retina also are affected by diabetes, resulting in dysfunction and even degeneration of some neuronal cells. Retinal ganglion cells (RGCs) are the best studied of the retinal neurons with respect to the effect of diabetes. Although investigations are providing new information about RGCs in diabetes, including therapies to inhibit the neurodegeneration, critical information about the function, anatomy and response properties of these cells is yet needed to understand the relationship between RGC changes and visual dysfunction in diabetes.

(Received 10 May 2008; accepted after revision 4 June 2008; first published online 19 June 2008)
Corresponding author T. S Kern: Center for Diabetes Research, Dept of Medicine, 434 Biomedical Research Building, Case Western Reserve University, 0900 Euclid Ave, Cleveland, OH 44106, USA.  Email: tsk{at}case.edu


This report was presented at The Journal of Physiology Symposium on Retinal ganglion cells in model organisms: development, function and disease, which took place in Fort Lauderdale, FL, USA, 26 April 2008. It was commissioned by the Editorial Board and reflects the views of the authors.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
F. Mazzoni, E. Novelli, and E. Strettoi
Retinal Ganglion Cells Survive and Maintain Normal Dendritic Morphology in a Mouse Model of Inherited Photoreceptor Degeneration
J. Neurosci., December 24, 2008; 28(52): 14282 - 14292.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Z. J. Zhou and M. A. McCall
Retinal ganglion cells in model organisms: development, function and disease
J. Physiol., September 15, 2008; 586(18): 4343 - 4345.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 The Physiological Society.